Heron Therapeutics, Inc. (HRTX)

0.3242 -0.01 (-2.38%) USD  |  NASDAQ  |  Aug 28, 16:00
0.3242 0.00 (0.00%) After-Hours: 20:00
More

Heron Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for HRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 11, 2026 --
August 10, 2026 --
June 27, 2026 --
June 03, 2026 --
June 02, 2026 --
May 11, 2026 --
April 23, 2026 --
April 16, 2026 --
March 31, 2026 --
March 26, 2026 --
February 26, 2026 --
December 31, 2025 --
November 04, 2025 --
August 08, 2025 --
June 09, 2025 --
May 07, 2025 --
April 17, 2025 --
Date Value
March 31, 2025 --
February 27, 2025 --
January 24, 2025 --
December 31, 2024 --
December 04, 2024 --
November 13, 2024 --
November 12, 2024 --
November 01, 2024 --
September 30, 2024 --
September 25, 2024 --
August 07, 2024 --
August 06, 2024 --
July 31, 2024 --
July 03, 2024 --
May 08, 2024 --
May 07, 2024 --
April 23, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Praxis Precision Medicines, Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade